Recovery After Robotic Urogynecological Surgery: The Patient's Perspective

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

The purpose of the study is to describe the patient experience, including pain scores, use of pain medications, resumption of usual activities, and bowel function in the post-operative period following robotic urogynecologic surgery. Additionally, to describe peri-operative parameters of robot-assisted urogynecologic surgery.

See also
Status	Clinical Trial	Phase
Completed	`NCT00919048` - Uroflow Measurements in Urogynecology Patients Compared to Healthy Female Volunteers	N/A
Completed	`NCT00757484` - Evaluation of Postoperative Blood Pressure Changes After Benign Gynecologic Surgery	N/A
Completed	`NCT01033786` - Robotic Urogynecological Surgery: Hospital Stay and Perioperative Complications
Recruiting	`NCT05885958` - Timing of Active Void Trials After Urogynecologic Procedures	N/A

NCT number	NCT00757432
Study type	Observational
Source	University of Rochester
Contact
Status	Completed
Phase	N/A
Start date	September 2007
Completion date	September 2008

Recovery After Robotic Urogynecological Surgery: The Patient's Perspective

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms